Health Catalyst, Inc.
Symbool: HCAT
NASDAQ
6.67
USDMarktprijs vandaag
-3.2448
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
393.75M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Health Catalyst, Inc. (HCAT) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 317.7 | 363.5 | 445 | |||||||
balance-sheet.row.short-term-investments | 0 | 211.5 | 247.2 | 251.8 | |||||||
balance-sheet.row.net-receivables | 0 | 61.2 | 48 | 48.8 | |||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.other-current-assets | 0 | 12.3 | 16.3 | 14.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 391.2 | 427.8 | 508.4 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 39.6 | 42.6 | 44.4 | |||||||
balance-sheet.row.goodwill | 0 | 190.7 | 186 | 170 | |||||||
balance-sheet.row.intangible-assets | 0 | 73.4 | 92.2 | 104.8 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 264 | 278.2 | 274.8 | |||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 6.9 | 3.7 | 4.5 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 310.6 | 324.5 | 323.7 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 701.8 | 752.3 | 832.1 | |||||||
balance-sheet.row.account-payables | 0 | 6.6 | 4.4 | 4.7 | |||||||
balance-sheet.row.short-term-debt | 0 | 3.4 | 3.4 | 3.4 | |||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 228 | 244.5 | 201.2 | |||||||
Deferred Revenue Non Current | 0 | 0.1 | 0.1 | 0.9 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 23.3 | 19.7 | 28.3 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 245.9 | 244.8 | 216.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 17.7 | 21.5 | 23.7 | |||||||
balance-sheet.row.total-liab | 0 | 334.9 | 327.3 | 310 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 1484.1 | 1424.7 | 0.1 | |||||||
balance-sheet.row.retained-earnings | 0 | -1117.2 | -999 | -878.9 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.6 | -0.1 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 1401 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 366.9 | 425 | 522.1 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 701.8 | 752.3 | 832.1 | |||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-equity | 0 | 366.9 | 425 | 522.1 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 211.5 | 247.2 | 251.8 | |||||||
balance-sheet.row.total-debt | 0 | 249.1 | 248 | 204.6 | |||||||
balance-sheet.row.net-debt | 0 | 142.8 | 131.7 | 11.4 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -118.1 | -137.4 | -153.2 | |||||||
cash-flows.row.depreciation-and-amortization | 0 | 45.2 | 48.3 | 37.5 | |||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -4.5 | -7.1 | |||||||
cash-flows.row.stock-based-compensation | 0 | 55.8 | 72.1 | 65.1 | |||||||
cash-flows.row.change-in-working-capital | 0 | -13.7 | -13.9 | 4.6 | |||||||
cash-flows.row.account-receivables | 0 | -13.7 | 0.8 | 0.1 | |||||||
cash-flows.row.inventory | 0 | 0 | 0 | -8.3 | |||||||
cash-flows.row.account-payables | 0 | 4.9 | -4.7 | 5.2 | |||||||
cash-flows.row.other-working-capital | 0 | -4.9 | -10 | 7.6 | |||||||
cash-flows.row.other-non-cash-items | 0 | -2.2 | 0.2 | 29.9 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -14.3 | -17.4 | -18.5 | |||||||
cash-flows.row.acquisitions-net | 0 | -11.4 | -27.8 | -46.8 | |||||||
cash-flows.row.purchases-of-investments | 0 | -290.8 | -309 | -261.4 | |||||||
cash-flows.row.sales-maturities-of-investments | 0 | 336.8 | 315.2 | 186.9 | |||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 20.3 | -39 | -139.7 | |||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.common-stock-issued | 0 | 4.5 | 4 | 245.2 | |||||||
cash-flows.row.common-stock-repurchased | 0 | -1.8 | -8.4 | 0 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | 0 | 4.5 | 1.8 | 18.9 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 2.7 | -2.6 | 264.1 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.net-change-in-cash | 0 | -10 | -76.9 | 101.3 | |||||||
cash-flows.row.cash-at-end-of-period | 0 | 106.3 | 116.3 | 193.2 | |||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 116.3 | 193.2 | 92 | |||||||
cash-flows.row.operating-cash-flow | 0 | -33.1 | -35.3 | -23.1 | |||||||
cash-flows.row.capital-expenditure | 0 | -14.3 | -17.4 | -18.5 | |||||||
cash-flows.row.free-cash-flow | 0 | -47.4 | -52.7 | -41.6 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 295.9 | 276.2 | 241.9 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 203.3 | 143 | 124.4 | |||||||
income-statement-row.row.gross-profit | 0 | 92.6 | 133.2 | 117.6 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 0 | 48.3 | 37.5 | |||||||
income-statement-row.row.operating-expenses | 0 | 178.4 | 273.2 | 261.2 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 381.7 | 416.2 | 385.6 | |||||||
income-statement-row.row.interest-income | 0 | 16.4 | 5.7 | 0.8 | |||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 1.7 | 16.5 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -32 | -1.7 | -16.5 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 48.3 | 37.5 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -32 | -1.7 | -16.5 | |||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 1.7 | 16.5 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 45.2 | 48.3 | 37.5 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | -85.8 | -140 | -143.7 | |||||||
income-statement-row.row.income-before-tax | 0 | -117.8 | -141.7 | -160.1 | |||||||
income-statement-row.row.income-tax-expense | 0 | 0.4 | -4.3 | -6.9 | |||||||
income-statement-row.row.net-income | 0 | -118.1 | -137.4 | -153.2 |
Vaak gestelde vragen
Wat is Health Catalyst, Inc. (HCAT) totale activa?
Health Catalyst, Inc. (HCAT) totale activa is 701814000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.418.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.399.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.391.
Wat is Health Catalyst, Inc. (HCAT) nettowinst (netto-inkomen)?
De nettowinst is -118147000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 249068000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 178360000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.